TikToker's low testosterone symptoms in women, fact-checked
Quick answer
Testosterone therapy in women involves off-label use of male formulations at 1-10mg daily doses, primarily for postmenopausal women with sexual dysfunction. The 2019 Lancet meta-analysis found modest improvements in sexual function but highlighted the lack of FDA-approved female testosterone products and potential for permanent virilizing side effects.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this TikTok actually claim?
@itsourremedy responds to another user by listing symptoms of low testosterone in women, drawing from her personal experience with the condition. She doesn't specify exact symptoms in the caption, but positions herself as someone who's been through surgical menopause and testosterone deficiency.
The video targets women going through perimenopause, menopause, or surgical menopause who might be experiencing hormone-related symptoms. Her approach combines personal experience with educational content about female testosterone deficiency.
Is low testosterone actually a thing in women?
Yes, and it's more common than many realize. Women produce testosterone in their ovaries and adrenal glands, with normal levels ranging from 15-70 ng/dL compared to men's 300-1000 ng/dL range.
The Melbourne Women's Midlife Health Project (Davis et al., Journal of Clinical Endocrinology & Metabolism, 2019) found that testosterone levels decline by about 50% between ages 20-45 in women. After surgical menopause, levels can drop even more dramatically since the ovaries are removed.
Common symptoms include decreased libido, fatigue, mood changes, and reduced muscle mass. However, diagnosing low testosterone in women remains tricky because normal ranges vary widely and symptoms overlap with other conditions.
What does the research say about treatment?
The evidence for testosterone therapy in women is mixed but growing. The Global Consensus Statement on Menopausal Hormone Therapy (Davis et al., Climacteric, 2019) recommends testosterone therapy specifically for postmenopausal women with hypoactive sexual desire disorder.
A meta-analysis by Davis et al. (Lancet Diabetes & Endocrinology, 2019) reviewed 36 trials involving 8,480 women. They found testosterone therapy improved sexual function scores by 0.37 points on validated scales and increased satisfying sexual episodes by 0.8 per month.
But here's where it gets complicated. The FDA hasn't approved any testosterone products specifically for women. Most prescriptions are compounded or off-label use of male formulations at lower doses, typically 1-10mg daily versus men's 50-100mg doses.
What should women actually know about this?
Getting tested isn't straightforward. Total testosterone levels fluctuate throughout the menstrual cycle and can be unreliable in women. Free testosterone measurements are more accurate but require specialized lab techniques that many standard tests don't use.
The Endocrine Society's 2014 guidelines actually recommend against routine testosterone testing in women because reference ranges are poorly defined. Many experts now focus on symptoms rather than just lab numbers when considering treatment.
Side effects matter too. The Australian longitudinal study (Glintborg et al., Clinical Endocrinology, 2018) found that 12% of women experienced acne, 8% had voice changes, and 3% developed male-pattern hair growth on testosterone therapy. These changes can be permanent even after stopping treatment.
If you're experiencing symptoms like persistent fatigue, low libido, or mood changes after menopause, talk to a healthcare provider experienced in women's hormone therapy. Don't rely solely on social media for medical guidance, even from well-meaning creators sharing their experiences.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TikToker's low testosterone symptoms in women, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
TikToker's low testosterone symptoms in women, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone therapy in women involves off-label use of male formulations at 1-10mg daily doses, primarily for postmenopausal women with sexual dysfunction.
FormBlends verdict
Testosterone therapy in women involves off-label use of male formulations at 1-10mg daily doses, primarily for postmenopausal women with sexual dysfunction. The 2019 Lancet meta-analysis found modest improvements in sexual function but highlighted the lack of FDA-approved female testosterone products and potential for permanent virilizing side effects.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy in women involves off-label use of male formulations at 1-10mg daily doses, primarily for postmenopausal women with sexual dysfunction. The 2019 Lancet meta-analysis found modest improvements in sexual function but highlighted the lack of FDA-approved female testosterone products and potential for permanent virilizing side effects.
- Women's testosterone levels drop 50% between ages 20-45, with steeper declines after surgical menopause
- The 2019 Lancet meta-analysis found testosterone therapy increased satisfying sexual episodes by 0.8 per month in postmenopausal women
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Women's testosterone levels drop 50% between ages 20-45, with steeper declines after surgical menopause
- The 2019 Lancet meta-analysis found testosterone therapy increased satisfying sexual episodes by 0.8 per month in postmenopausal women
- No FDA-approved testosterone products exist for women; most prescriptions are off-label use of male formulations
- Side effects include permanent voice changes (8% of users) and male-pattern hair growth (3% of users) per Australian studies
- The Endocrine Society recommends against routine testosterone testing in women due to poorly defined reference ranges
- Diagnosis should focus on symptoms rather than lab numbers, according to current clinical guidelines
- Free testosterone measurements are more accurate than total testosterone levels in women but require specialized testing
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Our Remedy · TikTok creator
57.7K views on this video
Replying to @Viola.co.uk the symptoms of low testosterone in women from someone who is female and had low testosterone 🤣 #menopause #perimenopause #surgicalmenopause #testosterone #hrt #hormonereplac
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Our Remedy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.